DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by World Investment Advisors

World Investment Advisors decreased its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 92.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,629 shares of the company's stock after selling 34,645 shares during the period. World Investment Advisors' holdings in DocuSign were worth $236,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Kestra Investment Management LLC purchased a new position in shares of DocuSign in the 4th quarter valued at approximately $30,000. Modus Advisors LLC purchased a new position in shares of DocuSign in the fourth quarter worth $36,000. First Horizon Advisors Inc. lifted its stake in shares of DocuSign by 102.6% during the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock worth $36,000 after buying an additional 201 shares during the period. Avion Wealth grew its holdings in shares of DocuSign by 309.2% during the fourth quarter. Avion Wealth now owns 487 shares of the company's stock valued at $43,000 after buying an additional 368 shares during the last quarter. Finally, Avior Wealth Management LLC grew its holdings in shares of DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company's stock valued at $49,000 after buying an additional 145 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

DocuSign Stock Performance

Shares of DocuSign stock traded up $1.33 on Tuesday, hitting $76.59. The company's stock had a trading volume of 408,578 shares, compared to its average volume of 2,716,570. The company has a market capitalization of $15.51 billion, a price-to-earnings ratio of 15.79, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The firm has a fifty day moving average price of $82.52 and a 200-day moving average price of $82.99.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $776.25 million during the quarter, compared to analysts' expectations of $760.94 million. During the same period in the previous year, the business earned $0.76 earnings per share. The business's revenue was up 9.0% compared to the same quarter last year. As a group, analysts forecast that DocuSign, Inc. will post 1.17 EPS for the current year.

Insider Transactions at DocuSign

In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the sale, the chief financial officer now owns 77,851 shares of the company's stock, valued at $6,765,251.90. The trade was a 9.32 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now directly owns 8,270 shares of the company's stock, valued at $722,880.70. The trade was a 6.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 47,851 shares of company stock valued at $3,998,719 over the last ninety days. Insiders own 1.66% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Citigroup lifted their price target on DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a research report on Friday, March 14th. UBS Group decreased their target price on DocuSign from $100.00 to $90.00 and set a "neutral" rating for the company in a report on Friday, March 14th. JPMorgan Chase & Co. upgraded shares of DocuSign from an "underweight" rating to a "neutral" rating and increased their price target for the stock from $70.00 to $75.00 in a report on Monday, March 10th. Needham & Company LLC restated a "hold" rating on shares of DocuSign in a research note on Friday, March 14th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $124.00 price objective on shares of DocuSign in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $93.85.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.